Galecto Inc
NASDAQ:GLTO
Galecto Inc
NASDAQ:GLTO
Price:
0.705 USD
-0.72%
Market Closed
Updated:
May 9, 2024
Galecto Inc
Operating Expenses
|
Galecto Inc
Operating Expenses Peer Comparison
Comparables:
GMAB
ZEAL
ASND
B
BAVA
BIOPOR
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Galecto Inc
NASDAQ:GLTO
|
Operating Expenses
-$36.5m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Genmab A/S
CSE:GMAB
|
Operating Expenses
-kr11.7B
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
-34%
|
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Operating Expenses
-kr884.9m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-16%
|
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Operating Expenses
-€642.7m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Operating Expenses
-kr2.5B
|
CAGR 3-Years
-107%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-14%
|
|
|
Bioporto A/S
CSE:BIOPOR
|
Operating Expenses
-kr80.3m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-11%
|
See Also
What is Galecto Inc's Operating Expenses?
Operating Expenses
-36.5m
USD
-36.5m
USD
Based on the financial report for Dec 31, 2023, Galecto Inc's Operating Expenses amounts to -36.5m USD.
What is Galecto Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-23%
-23%
Over the last year, the Operating Expenses growth was 40%. The average annual Operating Expenses growth rates for Galecto Inc have been -3% over the past three years , -23% over the past five years .
You don't have any saved screeners yet
